BioStem Technologies Commends OIG's Recommendation for CMS to Address ASP Reporting Requirements for Skin Substitute Products
23. März 2023 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., March 23, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies (“BioStem” or the “Company”) (OTCQB: BSEM), a leading provider of innovative regenerative medicine solutions, is...
BioStem Technologies Enters Into a Share Exchange Agreement
14. Februar 2023 08:55 ET
|
BioStem Technologies, Inc.
The Company will Acquire Back 10% of Issued and Outstanding Shares of its Non-Wholly Owned Subsidiary and Manufacturing Division POMPANO BEACH, FLORIDA., Feb. 14, 2023 (GLOBE NEWSWIRE) -- BioStem...
Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions
24. Januar 2023 07:30 ET
|
BioStem Technologies, Inc.
Pricing Provides VENDAJETM Reimbursement in All MAC Regions POMPANO BEACH, FLORIDA., Jan. 24, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine...
BioStem Technologies Announces Up-Listing to the OTCQB Venture Market
16. Dezember 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Dec. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Announces Partnership with Kill Cliff FC
14. Dezember 2022 07:30 ET
|
BioStem Technologies, Inc.
Kill Cliff FC is One of the world’s largest MMA Training Centers with More Than 80 Professional Fighters POMPANO BEACH, FLORIDA., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:...
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
26. Oktober 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Oct. 26, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTC PINK: BSEM), a leading regenerative medicine company focused on the development,...
BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts
13. September 2022 07:30 ET
|
BioStem Technologies, Inc.
Standardized methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje® and Vendaje AC® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE...
BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe
08. September 2022 07:30 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies® CEO to Appear on the Benzinga All Access Show on June 17,2022
17. Juni 2022 09:25 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development,...
BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results
16. Mai 2022 12:25 ET
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., May 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...